TABLE 1.

Demographic and HIV-related characteristics of the 555 study individuals.

Characteristics	Total, n = 555	Bishkek, n = 202	Osh, n = 341	JAB, n = 12	p	Adj. p
Gender, n (%)
Male	282 (50.8)	98 (48.5)	180 (52.8)	4 (33.3)	0.41	1
Female	273 (49.2)	104 (51.5)	161 (47.2)	8 (66.7)
Age (years), n (%)
3–14	101 (18.2)	5 (2.5)	95 (27.9)	1 (8.3)	< 0.01	< 0.01
15–24	120 (21.6)	17 (6.9)	103 (30.2)	–
25–49	271 (48.8)	143 (71.1)	119 (34.9)	7 (66.7)
50–72	63 (11.4)	36 (17.9)	24 (7)	3 (25)
Years since HIV-1 diagnosis, median	8.1 (range: 1–19)	6.46 (range: 1–18)	9 (range: 2–19)	8.92 (range: 3–15)	< 0.01	< 0.01
Transmission mode, n (%)
Heterosexual	215 (38.7)	117 (57.9)	90 (26.4)	8 (66.7)	< 0.01	< 0.01
MSM	9 (1.6)	7 (3.5)	2 (0.6)	–
Vertical	70 (12.6)	8 (4)	60 (17.9)	1 (8.3)
PWID	103 (18.6)	61 (30.2)	40 (11.7)	3 (25)
Nosocomial	119 (21.4)	–	119 (34.9)	–
Unknown/No data	39 (7)	9 (4.5)	30 (8.8)	–
Pregnancy status, n (%) Pregnant	33 (12.1)	33 (31.7)	–	–	–	–
HIV-1 drug resistance mutations, n (%)
Yes No	149 (26.9) 406 (73.1)	50 (24.8) 152 (75.2)	97 (28.5) 245 (71.5)	2 (16.7) 9 (83.3)	0.3	0.91
Dual- and multi-class HIV-1 drug resistance, n (%)
Yes No	99 (66.4) 50 (33.6)	29 (56.9) 21 (43.1)	70 (72.2) 27 (27.8)	0 11 (100)	0.06	0.68
HIV-1 subtyping, n (%)
CRF02_AG	332 (59.8)	95 (47)	232 (68)	5 (41.7)	< 0.01	< 0.01
A6	184 (33.2)	90 (44.6)	89 (26.1)	5 (41.7)
CRF63_02A	10 (1.8)	4 (2)	4 (1.2)	2 (16.6)
Minor subtypes and recombinants	29 (5.2)	13 (6.4)	16 (4.7)	–

Numbers in bold indicate statistically significant associations. JAB, Jalal-Abad and Batken provinces; Adj. p, adjusted p-value; MSM, men who have sex with men; PWID, persons who inject drugs; CRF, circulating recombinant form.